AVBP

NASDAQ · Biotechnology

Arrivent Biopharma Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$30.84

-0.17 (-0.55%)

As of Aug 8, 10:13 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target -17.0% upside

Low Target $15.99

Average Target $25.60

High Target $32.44

Current Price $30.84

Current
$30.84

Target
$25.60

$15.99 $25.60 avg $32.44

Scenario Analysis

Bear Case

$15.99

-48.2%

Low target

Base Case

$25.60

-17.0%

Avg target

Bull Case

$32.44

+5.2%

High target

Risk/Reward

0.1x

Unfavorable

Price in Context

52-Week High

$35.83

-13.9% from high

52-Week Low

$16.10

+91.6% from low

Target vs 52W High

$25.60

-28.6% vs high

Next Earnings Report

Aug 18, 2026

until earnings

EPS Est: $-1.01

Earnings in 8 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.0%